# Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)

> Federal funding opportunity · **POSTED** · National Institutes of Health · close: **10/15/2027**

## Key facts

- **Opportunity ID:** 357433
- **Opportunity number:** PAR-25-184
- **Agency:** National Institutes of Health
- **Status:** posted
- **Document type:** synopsis
- **Open date:** 11/26/2024
- **Close date:** 10/15/2027
- **CFDA codes:** 93.242

## Primary source

Grants.gov opportunity detail: https://www.grants.gov/search-results-detail/357433

## Citation

> US Grants.gov, funding opportunity 357433 (PAR-25-184). Retrieved via AI Analytics 2026-05-19 from https://api.ai-analytics.org/opportunity/357433. Licensed CC0.

---

*[Grants.gov dataset](/datasets/grants-gov) · CC0 1.0*